rs30527
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001098811.2(SEPTIN8):c.30+3058C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.354 in 158,716 control chromosomes in the GnomAD database, including 16,587 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.36 ( 16329 hom., cov: 32)
Exomes 𝑓: 0.28 ( 258 hom. )
Consequence
SEPTIN8
NM_001098811.2 intron
NM_001098811.2 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.459
Publications
12 publications found
Genes affected
SEPTIN8 (HGNC:16511): (septin 8) This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.78 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.357 AC: 54287AN: 151976Hom.: 16287 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
54287
AN:
151976
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.276 AC: 1830AN: 6622Hom.: 258 Cov.: 0 AF XY: 0.280 AC XY: 903AN XY: 3220 show subpopulations
GnomAD4 exome
AF:
AC:
1830
AN:
6622
Hom.:
Cov.:
0
AF XY:
AC XY:
903
AN XY:
3220
show subpopulations
African (AFR)
AF:
AC:
1
AN:
2
American (AMR)
AF:
AC:
0
AN:
2
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
2
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
AC:
1805
AN:
6516
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
8
AN:
48
Other (OTH)
AF:
AC:
16
AN:
52
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
63
126
188
251
314
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.358 AC: 54398AN: 152094Hom.: 16329 Cov.: 32 AF XY: 0.363 AC XY: 26961AN XY: 74346 show subpopulations
GnomAD4 genome
AF:
AC:
54398
AN:
152094
Hom.:
Cov.:
32
AF XY:
AC XY:
26961
AN XY:
74346
show subpopulations
African (AFR)
AF:
AC:
32666
AN:
41500
American (AMR)
AF:
AC:
4480
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
487
AN:
3470
East Asian (EAS)
AF:
AC:
3826
AN:
5154
South Asian (SAS)
AF:
AC:
794
AN:
4820
European-Finnish (FIN)
AF:
AC:
3075
AN:
10572
Middle Eastern (MID)
AF:
AC:
49
AN:
294
European-Non Finnish (NFE)
AF:
AC:
8391
AN:
67976
Other (OTH)
AF:
AC:
614
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1147
2295
3442
4590
5737
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1493
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.